Igalmi (Dexmedetomidine) Sublingual Film To Transform Acute Agitation & Aggression ...
The Business Research Company's Igalmi (Dexmedetomidine) Sublingual film to Transform Acute Agitation & Aggression Treatment Market in 2025 LONDON, GREATER LONDON, UNITED KINGDOM, January 31, 2025 ...
MarketBeat on MSN16 小时
Is Tonix Pharmaceuticals the Next Biotech Breakout?
Clinical-stage biopharmaceutical company Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant attention from investors ...
来自MSN16 小时
What Is Allergy Immunotherapy, and Does It Work?
Allergy medications not doing the job this season? Experts explain why allergy immunotherapy may be the newest answer to ...
The Pharma Letter22 小时
First-in-class treatment approved by NICE for allergic rhinitis
UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended Acarizax (12 ...
H.C. Wainwright Remains a Buy on Bioxcel Therapeutics (BTAI)
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Bioxcel Therapeutics (BTAI – Research Report) yesterday and set a price target ...
Chronic Pain Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse ...
Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic health condition, such as arthritis. The rising prevalence of chronic pain drives market growth by ...